Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-07-29 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −25,000 25,000
2013-07-29 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion +9,375 32,164
2013-07-29 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −9,375 9,375
2013-06-20 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-06-20 PIEN HOWARD H Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-06-20 MILANO VINCENT Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-06-20 COLA MICHAEL F Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-06-20 Galson Steven K Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-06-20 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-04-15 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2013-04-15 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Restricted Stock Unit +50,000 50,000
2013-02-14 Repella Robert SVP & Cheif Commercial Officer Exercise or conversion +15,000 15,000
2013-02-14 Repella Robert SVP & Cheif Commercial Officer Exercise or conversion · Restricted Stock Unit −15,000 45,000
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +18,750 447,400
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 459,900
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 472,400
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Shares withheld for taxes −16,836 $3.95 $67K 455,564
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −18,750 18,750
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −12,500 25,000
2013-02-14 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −12,500 37,500

Page 34 of 36 · 717 trades